top of page

Lecture 22: Growth Factors in Cancer

Gerald A Soff MD &
​​Hanny Al-Samkari M.D.

Presentation Date: 

March 5, 2026

About This Lecture

  • Cytopenia resulting from chemotherapy and other cancer treatments, is associated with morbidity/ mortality, and may negatively impact cancer outcomes. 

  • The development of therapeutic Hematopoietic Growth Factors has been one of the most impactful contributions to cancer care. 

  • In this presentation we will discuss the approach to cytopenia and the current understanding of appropriate use of growth factors in cancer patients.

Speaker Disclosures

Disclosures: Gerald Soff, M.D
Research Support (Past 2 years): Amgen, Sobi/Dova Pharmaceuticals, Anthos Therapeutics
Data Safety Monitoring Committee: Alpine Immune Sciences
Advisory Boards (Past 2 years) Sanofi, Novartis







Disclosures: Hanny Al-Samkari, M.D.
Research Support: Agios ,Sobi, Amgen, Novartis, Vaderis
Data Safety Monitoring Committee: Alpine Immune Sciences
Consultancy: Agios, Sobi, Argenx, Novartis, Alnylam, Sanofi, Amgen, Pharmacosmos

Learning Objectives

> Discuss the current approach to chemotherapy/cancer associated anemia.
> Discuss the current approach to chemotherapy/cancer associated neutropenia, including the approrpiate use of white cell growth factors.
> Discuss the current approach to chemotherapy induced thrombocytopenia

bottom of page